Clinical Studies Sponsored by Cognition Therapeutics

Clinical Studies Sponsored by Cognition Therapeutics

Clinical Studies Sponsored by University of Kansas

Clinical Studies Sponsored by Novavax

Clinical Studies Sponsored by Oxford BioMedica

List of awards received by Sacha Baron Cohen

List of SBIR/STTR awards granted to Square One Systems Design, Inc.

Clinical Studies where

Trial Sponsor

is

	Name	Description	NCT Number	Health Conditions in Trial	Clinical Trial Start Date	Study Completion Date	Clinical Trial Study Type
	‌ Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG		NCT04735536		July 9, 2020	April 26, 2023	Interventional
	‌ A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease		NCT03507790		October 10, 2018	July 26, 2024	Interventional
	‌ Study to Assess the Pharmacokinetics of CT1812 in Older Healthy Volunteers		NCT05248672		February 15, 2022	June 1, 2022	Interventional
	‌ Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease		NCT03522129		May 30, 2018	February 6, 2019	Interventional
	‌ Effect of CT1812 Treatment on Brain Synaptic Density		NCT03493282		March 28, 2018	October 16, 2020	Interventional
	‌ Ascending Dose Study of CT1812 in Healthy Volunteers		NCT02570997		2015		Interventional
	‌ Drug Interaction Study of CT1812 in Healthy Volunteers		NCT03716427		November 10, 2016	February 15, 2017	Interventional
	‌ Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD)		NCT05893537		June 16, 2023	August 15, 2027	Interventional
	‌ Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease		NCT02907567	Alzheimer's disease	2016	2017	Interventional

9 results

0 selected

9 results

0 selected